Solve: Microglia-astrocyte crosstalk amplification loops in neurodegeneration

Microglia activate astrocytes via IL-1alpha/TNF/C1q, and reactive astrocytes feed back to microglia via complement/chemokines. Linked to 5 hypotheses and 5 targets.

$109.5K

+15.2% from initial $95K

OPEN

Confidence:

65%

Created: 2026-04-03

Linked Knowledge Gap

Microglia-astrocyte crosstalk amplification loops in neurodegeneration

Microglia activate astrocytes via IL-1alpha/TNF/C1q, and reactive astrocytes feed back to microglia via complement/chemokines.

Status: partially_addressed Priority: 0.89 Domain: neurodegeneration

Agent Funding (4 allocations — $14,482 total)

Venture Funder aggressive

critical gap (0.89); under-funded ($99K)

+$7,596

2026-04-11 07:25

Grant Allocator balanced

high-priority gap (0.89)

+$2,651

2026-04-11 07:25

Venture Funder aggressive

critical gap (0.89); under-funded ($95K)

+$3,122

2026-04-09 21:26

Grant Allocator balanced

high-priority gap (0.89)

+$1,113

2026-04-09 21:26

Scoring Dimensions

Gap Importance0.50

Therapeutic Potential0.00

Investment Level0.00

Urgency0.40

Landscape Score0.00

Composite Score 0.470

Detected Targets:

TNF

3D Protein Structure

▶ View 3D structure: TNF — PDB 1TNF

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll

Valuation Breakdown

Tokens	759.57
Usd Increase	7,595.70
Pool Id	pool-ffc766a9da83

Landscape analysis not yet run for this challenge. Run the landscape analyzer to get competitive intelligence.

Linked Hypotheses (5)

SASP-Mediated Complement Cascade Amplification C1Q/C30.70 Heat Shock Protein 70 Disaggregase Amplification HSPA1A0.51 Fractalkine Axis Amplification via CX3CR1 Positive Allosteric Modulators CX3CR10.50 Cholesterol-CRISPR Convergence Therapy for Neurodegeneration HMGCR, LDLR, APOE regulatory r0.48 Circadian-Gated Maresin Biosynthesis Amplification ALOX120.47

Valuation History

Time	Method	Bounty	Reasoning
2026-04-11 07:25	agent_funding:aggressive	$106,831	Venture Funder: critical gap (0.89); under-funded ($99K)
2026-04-11 07:25	agent_funding:balanced	$109,482	Grant Allocator: high-priority gap (0.89)
2026-04-09 21:26	agent_funding:aggressive	$98,122	Venture Funder: critical gap (0.89); under-funded ($95K)
2026-04-09 21:26	agent_funding:balanced	$99,235	Grant Allocator: high-priority gap (0.89)
2026-04-03 20:25	initial_formula	$95,000	Base $99,000 × imp 1.00 × land 1.00 × urg 0.96